Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 26(33): 4863-71, 2007 Jul 19.
Article in English | MEDLINE | ID: mdl-17297445

ABSTRACT

Loss of JunB has been observed in human leukemia and lymphoma, but it remains unknown, whether this loss is relevant to disease progression. Here, we investigated the consequences of JunB deficiency using Abelson-induced B-lymphoid leukemia as a model system. Mice deficient in JunB expression succumbed to Abelson-induced leukemia with increased incidence and significantly reduced latency. Similarly, bcr/abl p185-transformed JunB-deficient (junB(Delta/Delta)) cells induced leukemia in RAG2(-/-) mice displaying a more malignant phenotype. These observations indicated that cell intrinsic effects within the junB(Delta/Delta) tumor cells accounted for the accelerated leukemia development. Indeed, explantated bcr/abl p185 transformed junB(Delta/Delta) cells proliferated faster than the control cells. The proliferative advantage emerged slowly after the initial transformation process and was associated with increased expression levels of the cell cycle kinase cdk6 and with decreased levels of the cell cycle inhibitor p16(INK4a). These alterations were due to irreversible reprogramming of the cell, because - once established - accelerated disease induced by junB(Delta/Delta) cells was not reverted by re-introducing JunB. Consistent with this observation, we found that the p16 promoter was methylated. Thus, JunB functions as a gatekeeper during tumor evolution. In its absence, transformed leukemic cells acquire an enhanced proliferative capacity, which presages a more malignant disease.


Subject(s)
Leukemia, Lymphoid/pathology , Proto-Oncogene Proteins c-jun/physiology , Animals , Blotting, Western , Cell Line , Cell Line, Tumor , Cell Proliferation , Cell Survival , Cells, Cultured , Cyclin-Dependent Kinase 6/genetics , Cyclin-Dependent Kinase 6/metabolism , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/physiology , Flow Cytometry , Fusion Proteins, bcr-abl/genetics , Fusion Proteins, bcr-abl/metabolism , Fusion Proteins, bcr-abl/physiology , Gene Expression , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Leukemia, Experimental/genetics , Leukemia, Experimental/metabolism , Leukemia, Experimental/pathology , Leukemia, Lymphoid/genetics , Leukemia, Lymphoid/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Nude , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transfection
2.
Oncogene ; 20(18): 2205-11, 2001 Apr 26.
Article in English | MEDLINE | ID: mdl-11402315

ABSTRACT

Smad proteins transduce signals from TGF-beta receptors and regulate transcription of target genes. Among the latter are c-jun and junB, which encode members of the AP-1 family of transcription factors. In this study, we have investigated the functional interactions of the Smad and AP-1 transcription factors in the context of Smad-specific gene transactivation in both fibroblasts and keratinocytes. We demonstrate that overexpression of either junB or c-jun prevents TGF-beta- or Smad3-induced transactivation of the Smad-specific promoter construct (SBE)(4)-Lux. Inversely, Smad-driven promoter transactivation by TGF-beta/Smad is significantly enhanced when c-jun expression is abolished in HaCaT keratinocytes, and when junB expression is prevented in fibroblasts, consistent with the cell-type specific induction of jun members by TGF-beta. We also demonstrate that Smad-specific gene transactivation in junB(-/-) mouse embryonic fibroblasts is significantly higher than in embryonic fibroblasts from the control parental mouse line, and that this difference is abolished by rescuing junB expression in junB(-/-) cells. Finally, we have determined that off-DNA interactions between Smad3 and both c-Jun and JunB result in the reduction of Smad3/DNA interactions. From these results, we provide a model in which jun expression in response to the initial Smad cascade represents a negative feed-back mechanism counteracting Smad-driven gene transactivation.


Subject(s)
DNA-Binding Proteins/physiology , Proto-Oncogene Proteins c-jun/biosynthesis , Trans-Activators/physiology , Transcription Factor AP-1/biosynthesis , Transcriptional Activation/physiology , Transforming Growth Factor beta/physiology , Animals , COS Cells , DNA/genetics , DNA/metabolism , DNA, Antisense/genetics , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/genetics , Fibroblasts/physiology , Genes, jun/genetics , Humans , Keratinocytes/physiology , Mice , Proto-Oncogene Proteins c-jun/genetics , Smad3 Protein , Trans-Activators/antagonists & inhibitors , Trans-Activators/genetics , Transcription Factor AP-1/genetics , Transcription Factor AP-1/physiology , Transfection , Transforming Growth Factor beta/antagonists & inhibitors
3.
Oncogene ; 20(19): 2413-23, 2001 Apr 30.
Article in English | MEDLINE | ID: mdl-11402337

ABSTRACT

The mouse skin has become the model of choice to study the regulation and function of AP-1 subunits in many physiological and pathological processes in vivo and in vitro. Genetically modified mice, in vitro reconstituted skin equivalents and epidermal cell lines were established, in which AP-1-regulated genetic programs of cell proliferation, differentiation and tumorigenesis can be analysed. Since the epidermis, as our interface with the environment, is subjected to radiation and injury, signal transduction pathways and critical AP-1 members regulating the mammalian stress response could be identified. Regulated expression of important components of the cytokine network, cell surface receptors and proteases, which orchestrate the process of wound healing has been found to rely on AP-1 activity. Here we review our current knowledge on the function of AP-1 subunits and AP-1 target genes in these fascinating fields of skin physiology and pathology.


Subject(s)
Skin Neoplasms/etiology , Skin Physiological Phenomena , Transcription Factor AP-1/physiology , Animals , Cell Differentiation , Cell Division , Keratinocytes/cytology , Keratinocytes/metabolism , Mice , Models, Biological , Proto-Oncogene Proteins c-fos/physiology , Proto-Oncogene Proteins c-jun/physiology , Skin/metabolism , Skin Diseases/etiology , Transcription Factor AP-1/metabolism , Wound Healing
4.
J Invest Dermatol ; 116(5): 816-20, 2001 May.
Article in English | MEDLINE | ID: mdl-11348477

ABSTRACT

Organotypic cocultures of keratinocytes and fibroblasts generate a normal epidermis irrespective of the species and tissue origin of fibroblasts. The use of mouse fibroblasts and human keratinocytes facilitates the identification of the origin of compounds involved in epidermal tissue reconstitution and growth regulation. Moreover, the functional significance for the keratinocyte phenotype of genetically modified fibroblasts from transgenic or knockout mice, even those exhibiting an embryonic lethal phenotype, can be studied in such heterologous in vitro tissue equivalents. Here we communicate results of such studies revealing the antagonistic function of mouse fibroblasts defective in the AP-1 constituents c-Jun and JunB, respectively, on human keratinocyte growth and differentiation. Furthermore, the hematopoietic growth factor granulocyte macrophage-colony stimulating factor has been identified as a novel regulator of keratinocyte growth and differentiation. As will be reported in detail elsewhere both granulocyte macrophage-colony stimulating factor and keratinocyte growth factor have been identified as major mediators of fibroblast-keratinocyte interactions and their expression is induced via AP-1 by interleukin-1 released by the epithelial cells. Thus, these heterologous cocultures provide a novel promising tool for elucidating molecular mechanisms of epithelial-mesenchymal interactions and their consequences on epithelial cell proliferation and differentiation.


Subject(s)
Keratinocytes/cytology , Adult , Animals , Cell Differentiation/physiology , Cell Division/physiology , Embryo, Mammalian , Fibroblasts/metabolism , Humans , Mice , Mice, Knockout/genetics , Organ Culture Techniques , Proto-Oncogene Proteins c-jun/deficiency , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/physiology
5.
Cell ; 104(1): 21-32, 2001 Jan 12.
Article in English | MEDLINE | ID: mdl-11163237

ABSTRACT

The functions of JunB during myelopoiesis were studied in vivo. Transgenic mice specifically lacking JunB expression in the myeloid lineage (junB(-/-)Ubi-junB mice) develop a transplantable myeloproliferative disease eventually progressing to blast crisis, which resembles human chronic myeloid leukemia. Similarly, mice reconstituted with ES cell-derived junB-/- fetal liver cells also develop a myeloproliferative disease. In both cases, the absence of JunB expression results in increased numbers of granulocyte progenitors, which display enhanced GM-CSF-mediated proliferation and extended survival, associated with changes in the expression levels of the GM-CSFalpha receptor, the anti-apoptotic proteins Bcl2 and Bclx, and the cell cycle regulators p16(INK4a) and c-Jun. Importantly, ectopic expression of JunB fully reverts the immature and hyperproliferative phenotype of JunB-deficient myeloid cells. These results identify JunB as a key transcriptional regulator of myelopoiesis and a potential tumor suppressor gene.


Subject(s)
Granulocytes/cytology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/physiopathology , Proto-Oncogene Proteins c-jun/genetics , Stem Cells/cytology , Animals , Cell Differentiation/immunology , Cell Division/drug effects , Cell Division/immunology , Cell Lineage/immunology , Gene Expression/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , In Vitro Techniques , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Leukopoiesis/immunology , Mice , Mice, Knockout , Phenotype , Transgenes/immunology
6.
Cell ; 103(5): 745-55, 2000 Nov 22.
Article in English | MEDLINE | ID: mdl-11114331

ABSTRACT

Interactions between mesenchymal and epithelial cells are responsible for organogenesis and tissue homeostasis. This mutual cross-talk involves cell surface proteins and soluble factors, which are mostly the result of regulated transcription. To elucidate dimer-specific functions of the AP-1 family of transcription factors, we reconstituted skin by combining primary human keratinocytes and mouse wild-type, c-jun(-/-), and junB(-/-) fibroblasts. We have discovered an antagonistic function of these AP-1 subunits in the fibroblast-mediated paracrine control of keratinocyte proliferation and differentiation, and traced this effect to the IL-1-dependent regulation of KGF and GM-CSF. These data suggest that the relative activation state of these AP-1 subunits in a non-cell-autonomous, transregulatory fashion directs regeneration of the epidermis and maintenance of tissue homeostasis in skin.


Subject(s)
Cytokines/metabolism , Epidermis/metabolism , Mesoderm/metabolism , Proto-Oncogene Proteins c-jun/physiology , Skin/metabolism , Animals , Cell Differentiation , Cell Division , Cells, Cultured , Coculture Techniques , Collagen/metabolism , Enzyme-Linked Immunosorbent Assay , Estrogen Antagonists/pharmacology , Fibroblast Growth Factor 7 , Fibroblast Growth Factors/metabolism , Fibroblasts/metabolism , Fluorescent Antibody Technique, Indirect , Granulocyte-Macrophage Colony-Stimulating Factor/antagonists & inhibitors , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Keratinocytes/metabolism , Mice , Models, Biological , Mutation , RNA, Messenger/metabolism , Rats , Recombinant Fusion Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Tamoxifen/pharmacology , Transcription Factor AP-1/metabolism
7.
Oncogene ; 18(3): 667-78, 1999 Jan 21.
Article in English | MEDLINE | ID: mdl-9989817

ABSTRACT

PTH is a major regulator of calcium homeostasis by mobilizing calcium through bone resorption. We show that the expression of collagenase-3 (MMP-13), a member of the family of matrix metalloproteinases, required for the cleavage of collagens in the bone, is increased upon PTH injection in mice. A cis-acting element in the collagenase-3 promoter was identified which, together with AP-1, is required for induction by PTH. This element contains CCACA motifs which are required for binding of the 65 kDa osteoblast-specific splice variant of Cbfal. Introduction of mutations in this binding site that interfere with protein interaction also eliminates PTH inducibility and transactivation by Cbfa/ Runt proteins. While DNA binding activity of AP-1 is increased upon PTH treatment, high basal level of Cbfa/Runt binding activity is detectable in untreated cells which is not further increased by PTH, suggesting that AP-1 and Cbfal contribute to transcriptional activation through different mechanisms. In agreement with the critical role of both proteins defined in tissue culture cells, expression of collagenase-3 is reduced in mice lacking c-fos and is completely absent in cbfa1-/-embryos. These data provide the first evidence for a critical role of Cbfal, a major regulator of bone development, in PTH-dependent processes such as bone resorption.


Subject(s)
Collagenases/biosynthesis , DNA-Binding Proteins , Neoplasm Proteins , Parathyroid Hormone/pharmacology , Proto-Oncogene Proteins , Transcription Factor AP-1/metabolism , Transcription Factors/metabolism , Animals , Binding Sites , Collagenases/genetics , Core Binding Factor Alpha 1 Subunit , Core Binding Factor Alpha 2 Subunit , Enzyme Induction , Gene Expression Regulation, Enzymologic , Matrix Metalloproteinase 13 , Mice , Mice, Inbred C57BL , Promoter Regions, Genetic , Rats , Response Elements , Transcription, Genetic , Transcriptional Activation , Tumor Cells, Cultured
8.
EMBO J ; 18(4): 934-48, 1999 Feb 15.
Article in English | MEDLINE | ID: mdl-10022836

ABSTRACT

Lack of JunB, an immediate early gene product and member of the AP-1 transcription factor family causes embryonic lethality between E8.5 and E10.0. Although mutant embryos are severely retarded in growth and development, cellular proliferation is apparently not impaired. Retardation and embryonic death are caused by the inability of JunB-deficient embryos to establish proper vascular interactions with the maternal circulation due to multiple defects in extra-embryonic tissues. The onset of the phenotypic defects correlates well with high expression of junB in wild-type extra-embryonic tissues. In trophoblasts, the lack of JunB causes a deregulation of proliferin, matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (uPA) gene expression, resulting in a defective neovascularization of the decidua. As a result of downregulation of the VEGF-receptor 1 (flt-1), blood vessels in the yolk sac mesoderm appeared dilated. Mutant embryos which escape these initial defects finally die from a non-vascularized placental labyrinth. Injection of junB-/- embryonic stem (ES) cells into tetraploid wild-type blastocysts resulted in a partial rescue, in which the ES cell-derived fetuses were no longer growth retarded and displayed a normal placental labyrinth. Therefore, JunB appears to be involved in multiple signaling pathways regulating genes involved in the establishment of a proper feto-maternal circulatory system.


Subject(s)
Placentation , Proto-Oncogene Proteins c-jun/genetics , Transcription Factor AP-1/genetics , Animals , Cell Division/genetics , Embryonic and Fetal Development , Gene Expression Regulation, Developmental , Gene Targeting , Genotype , In Situ Hybridization , Mice , Mice, Knockout , Mutation/genetics , Phenotype , Placenta/blood supply , Ploidies , Proto-Oncogene Proteins c-jun/deficiency , Stem Cells/metabolism , Yolk Sac/embryology
SELECTION OF CITATIONS
SEARCH DETAIL
...